Search results for the GEO ID: GSE33769
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM833438
GPL570
fibroblast_patient_1_A human fibroblast, Q10 deficient patient 1, rep. 1 age: 12-year-old gender: girl clinical phenotype: (1) ataxia and cerebellar atrophy, (2) decreased mitochondrial enzimatic activities in complex I+III and complex II+III, and (3) CoQ concentration in muscle was decreased. treatment: After 16 months of CoQ supplementation, the patient is now able to walk unaided and cerebellar signs have disappeared.
GSM833441
GPL570
fibroblast_patient_1_B human fibroblast, Q10 deficient patient 1, rep. 2 age: 12-year-old gender: girl clinical phenotype: (1) ataxia and cerebellar atrophy, (2) decreased mitochondrial enzimatic activities in complex I+III and complex II+III, and (3) CoQ concentration in muscle was decreased. treatment: After 16 months of CoQ supplementation, the patient is now able to walk unaided and cerebellar signs have disappeared.
GSM833444
GPL570
fibroblast_patient_1_C human fibroblast, Q10 deficient patient 1, rep. 3 age: 12-year-old gender: girl clinical phenotype: (1) ataxia and cerebellar atrophy, (2) decreased mitochondrial enzimatic activities in complex I+III and complex II+III, and (3) CoQ concentration in muscle was decreased. treatment: After 16 months of CoQ supplementation, the patient is now able to walk unaided and cerebellar signs have disappeared. reference: Artuch, R. et al. Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation. J Neurol Sci 246, 153-8 (2006). PubMed ID: 16677673
GSM833478
GPL570
control_fibroblast_A human fibroblast, neonatal, rep. 1 cell type: Human dermal fibroblast (primary culture of cells) obtained from healthy voluntiers. age: neonatal
GSM833479
GPL570
control_fibroblast_B human fibroblast, neonatal, rep. 2 cell type: Human dermal fibroblast (primary culture of cells) obtained from healthy voluntiers. age: neonatal
GSM833480
GPL570
control_fibroblast_C human fibroblast, neonatal, rep. 3 cell type: Human dermal fibroblast (primary culture of cells) obtained from healthy voluntiers. age: neonatal
GSM833490
GPL570
fibroblast_patient_3_A human fibroblast, Q10 deficient patient COQ2 mutant, rep. 1 age: 33-month-old gender: boy cell type: dermal fibroblasts. clinical phenotype: (1) corticosteroid-resistant nephrotic syndrome, (2) progressive encephalomyopathy later developed, and (3) CoQ10 was decreased (muscle and fibroblasts). treatment: Oral CoQ10 improved the neurologic picture, but do not improved the renal dysfunction. reference: Salviati, L. et al. Neurology 65, 606-8 (2005)
GSM833491
GPL570
fibroblast_patient_3_B human fibroblast, Q10 deficient patient COQ2 mutant, rep. 2 age: 33-month-old gender: boy clinical phenotype: (1) corticosteroid-resistant nephrotic syndrome, (2) progressive encephalomyopathy later developed, and (3) CoQ10 was decreased (muscle and fibroblasts). treatment: Oral CoQ10 improved the neurologic picture, but do not improved the renal dysfunction. reference: 16116126 PubMed ID
GSM833492
GPL570
fibroblast_patient_3_C human fibroblast, Q10 deficient patient COQ2 mutant, rep. 3 age: 33-month-old gender: boy clinical phenotype: (1) corticosteroid-resistant nephrotic syndrome, (2) progressive encephalomyopathy later developed, and (3) CoQ10 was decreased (muscle and fibroblasts) treatment: Oral CoQ10 improved the neurologic picture, but do not improved the renal dysfunction. reference: 16116126 PubMed ID
GSM833493
GPL570
fibroblast_patient_5_A human fibroblast, Q10 deficient patient COQ2 mutant (sister), rep. 1 gender: girl reference: unpublished (sister of patient 3; reference 16116126 PubMed ID)
GSM833494
GPL570
fibroblast_patient_5_B human fibroblast, Q10 deficient patient COQ2 mutant (sister), rep. 2 gender: girl reference: unpublished (sister of patient 3; reference 16116126 PubMed ID)
GSM833495
GPL570
fibroblast_patient_5_C human fibroblast, Q10 deficient patient COQ2 mutant (sister), rep. 3 gender: girl reference: unpublished (sister of patient 3; reference 16116126 PubMed ID)
GSM833502
GPL570
fibroblast_patient_4_A human fibroblast, Q10 deficient patient, MELAS, rep. 1 cell type: fibroblast clinical phenotype: MELAS (A3243G mutation). cell phenotype: (1) decreased mitochondrial respiratory chain enzyme activities, (2) low CoQ10 level, (3) decreased mitochondrial membrane potential, (4) increased oxidative stress and the activation of mitochondrial permeability, and (5) defective autophagosome elimination in MELAS fibroblasts.
GSM833503
GPL570
fibroblast_patient_4_B human fibroblast, Q10 deficient patient, MELAS, rep. 2 cell type: fibroblast clinical phenotype: MELAS (A3243G mutation). cell phenotype: (1) decreased mitochondrial respiratory chain enzyme activities, (2) low CoQ10 level, (3) decreased mitochondrial membrane potential, (4) increased oxidative stress and the activation of mitochondrial permeability, and (5) defective autophagosome elimination in MELAS fibroblasts. reference: PubMed ID #21551238 - Cotan, D. et al. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. Faseb J 25, 2669-87 (2011).
GSM833504
GPL570
fibroblast_patient_4_C human fibroblast, Q10 deficient patient, MELAS, rep. 3 cell type: fibroblast clinical phenotype: MELAS (A3243G mutation). cell phenotype: (1) decreased mitochondrial respiratory chain enzyme activities, (2) low CoQ10 level, (3) decreased mitochondrial membrane potential, (4) increased oxidative stress and the activation of mitochondrial permeability, and (5) defective autophagosome elimination in MELAS fibroblasts. reference: PubMed ID #21551238 - Cotan, D. et al. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. Faseb J 25, 2669-87 (2011).
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes